Paul Tudor Jones Exact Sciences Corp Transaction History
Tudor Investment Corp Et Al
- $44 Billion
- Q2 2025
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Exact Sciences Corp stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 48,060 shares of EXAS stock, worth $3.05 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
48,060
Previous 10,530
356.41%
Holding current value
$3.05 Million
Previous $455,000
461.1%
% of portfolio
0.01%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding EXAS
# of Institutions
650Shares Held
156MCall Options Held
1.43MPut Options Held
2.3M-
Capital World Investors Los Angeles, CA18.2MShares$1.15 Billion0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.9MShares$1.14 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$765 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12MShares$761 Million0.12% of portfolio
-
State Street Corp Boston, MA5.38MShares$341 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $11.2B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...